Frank Rimerman Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.43M Sell
16,636
-666
-4% -$65.2K 0.08% 189
2026
Q2
$1.79M Buy
17,302
+6,714
+63% +$599K 0.1% 158
2026
Q1
$760K Sell
10,588
-3,978
-27% -$306K 0.05% 297
2025
Q4
$1.16M Buy
14,566
+4,089
+39% +$322K 0.07% 207
2025
Q3
$790K Sell
10,477
-24
-0.2% -$1.64K 0.05% 265
2025
Q2
$724K Sell
10,501
-2,988
-22% -$196K 0.05% 277
2025
Q1
$914K Buy
13,489
+1,702
+14% +$102K 0.07% 209
2024
Q4
$529K Buy
11,787
+4,571
+63% +$256K 0.04% 296
2024
Q3
$454K Sell
7,216
-2,108
-23% -$123K 0.03% 346
2024
Q2
$551K Buy
9,324
+9,225
+9,318% +$577K 0.04% 320
2024
Q1
$7.9K Hold
99
– – ﹤0.01% 185
2023
Q4
$7.82K Buy
+99
New +$7.05K ﹤0.01% 178

Other funds holding CVS

Frank Rimerman Advisors's CVS Position: Q3 2026 in Review

Frank Rimerman Advisors reduced its CVS Health (CVS) stake by 3.8% in Q3 2026, selling an estimated $65.2K and leaving 16,636 shares worth $1.43M. The position accounts for 0.08% of the portfolio, ranked #189.

Frank Rimerman Advisors first reported a position in CVS in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.79M in Q2 2026. 1,996 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Frank Rimerman Advisors held 16,636 shares of CVS Health worth $1.43M as of Q3 2026.
  • Frank Rimerman Advisors sold 666 CVS Health shares in Q3 2026, an estimated $65.2K.
  • CVS Health made up 0.08% of Frank Rimerman Advisors's portfolio in Q3 2026, its #189 holding.
  • Frank Rimerman Advisors first reported a position in CVS Health in Q4 2023 and has held it in 12 quarters since.
  • Frank Rimerman Advisors's CVS Health position peaked at $1.79M in Q2 2026.
  • 1,996 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Frank Rimerman Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.